157 related articles for article (PubMed ID: 20501662)
21. Modulators of the Inhibitory Glycine Receptor.
Breitinger U; Breitinger HG
ACS Chem Neurosci; 2020 Jun; 11(12):1706-1725. PubMed ID: 32391682
[TBL] [Abstract][Full Text] [Related]
22. Interaction of androsterone and progesterone with inhibitory ligand-gated ion channels: a patch clamp study.
Ziegler E; Bodusch M; Song Y; Jahn K; Wolfes H; Steinlechner S; Dengler R; Bufler J; Krampfl K
Naunyn Schmiedebergs Arch Pharmacol; 2009 Oct; 380(4):277-91. PubMed ID: 19705103
[TBL] [Abstract][Full Text] [Related]
23. Mapping of disulfide bonds within the amino-terminal extracellular domain of the inhibitory glycine receptor.
Vogel N; Kluck CJ; Melzer N; Schwarzinger S; Breitinger U; Seeber S; Becker CM
J Biol Chem; 2009 Dec; 284(52):36128-36136. PubMed ID: 19861413
[TBL] [Abstract][Full Text] [Related]
24. Developmental regulation of beta-carboline-induced inhibition of glycine-evoked responses depends on glycine receptor beta subunit expression.
Mangin JM; Nguyen L; Gougnard C; Hans G; Rogister B; Belachew S; Moonen G; Legendre P; Rigo JM
Mol Pharmacol; 2005 May; 67(5):1783-96. PubMed ID: 15722459
[TBL] [Abstract][Full Text] [Related]
25. Zinc enhances ethanol modulation of the alpha1 glycine receptor.
McCracken LM; Trudell JR; Goldstein BE; Harris RA; Mihic SJ
Neuropharmacology; 2010 Mar; 58(3):676-81. PubMed ID: 19913039
[TBL] [Abstract][Full Text] [Related]
26. Manipulations of extracellular Loop 2 in α1 GlyR ultra-sensitive ethanol receptors (USERs) enhance receptor sensitivity to isoflurane, ethanol, and lidocaine, but not propofol.
Naito A; Muchhala KH; Trang J; Asatryan L; Trudell JR; Homanics GE; Alkana RL; Davies DL
Neuroscience; 2015 Jun; 297():68-77. PubMed ID: 25827497
[TBL] [Abstract][Full Text] [Related]
27. Zinc potentiation of the glycine receptor chloride channel is mediated by allosteric pathways.
Lynch JW; Jacques P; Pierce KD; Schofield PR
J Neurochem; 1998 Nov; 71(5):2159-68. PubMed ID: 9798943
[TBL] [Abstract][Full Text] [Related]
28. Positive Allosteric Modulators of Glycine Receptors and Their Potential Use in Pain Therapies.
Gallagher CI; Ha DA; Harvey RJ; Vandenberg RJ
Pharmacol Rev; 2022 Oct; 74(4):933-961. PubMed ID: 36779343
[TBL] [Abstract][Full Text] [Related]
29. The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site.
Vandenberg RJ; Rajendra S; French CR; Barry PH; Schofield PR
Mol Pharmacol; 1993 Jul; 44(1):198-203. PubMed ID: 8393521
[TBL] [Abstract][Full Text] [Related]
30. Large Intracellular Domain-Dependent Effects of Positive Allosteric Modulators on Glycine Receptors.
Lara CO; Burgos CF; Silva-Grecchi T; Muñoz-Montesino C; Aguayo LG; Fuentealba J; Castro PA; Guzmán JL; Corringer PJ; Yévenes GE; Moraga-Cid G
ACS Chem Neurosci; 2019 May; 10(5):2551-2559. PubMed ID: 30893555
[TBL] [Abstract][Full Text] [Related]
31. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents.
Rigo JM; Hans G; Nguyen L; Rocher V; Belachew S; Malgrange B; Leprince P; Moonen G; Selak I; Matagne A; Klitgaard H
Br J Pharmacol; 2002 Jul; 136(5):659-72. PubMed ID: 12086975
[TBL] [Abstract][Full Text] [Related]
32. Crystal Structures of Human GlyRα3 Bound to Ivermectin.
Huang X; Chen H; Shaffer PL
Structure; 2017 Jun; 25(6):945-950.e2. PubMed ID: 28479061
[TBL] [Abstract][Full Text] [Related]
33. Identification of an inhibitory Zn2+ binding site on the human glycine receptor alpha1 subunit.
Harvey RJ; Thomas P; James CH; Wilderspin A; Smart TG
J Physiol; 1999 Oct; 520 Pt 1(Pt 1):53-64. PubMed ID: 10517800
[TBL] [Abstract][Full Text] [Related]
34. Mapping the neurosteroid binding sites on glycine receptors.
Alvarez LD; Pecci A
J Steroid Biochem Mol Biol; 2019 Sep; 192():105388. PubMed ID: 31176751
[TBL] [Abstract][Full Text] [Related]
35. Functional characterisation of the human alpha1 glycine receptor in a fluorescence-based membrane potential assay.
Jensen AA; Kristiansen U
Biochem Pharmacol; 2004 May; 67(9):1789-99. PubMed ID: 15081878
[TBL] [Abstract][Full Text] [Related]
36. Molecular requirements for ethanol differential allosteric modulation of glycine receptors based on selective Gbetagamma modulation.
Yevenes GE; Moraga-Cid G; Avila A; Guzmán L; Figueroa M; Peoples RW; Aguayo LG
J Biol Chem; 2010 Sep; 285(39):30203-13. PubMed ID: 20647311
[TBL] [Abstract][Full Text] [Related]
37. Differential localization of gamma-aminobutyric acid type A and glycine receptor subunits and gephyrin in the human pons, medulla oblongata and uppermost cervical segment of the spinal cord: an immunohistochemical study.
Waldvogel HJ; Baer K; Eady E; Allen KL; Gilbert RT; Mohler H; Rees MI; Nicholson LF; Faull RL
J Comp Neurol; 2010 Feb; 518(3):305-28. PubMed ID: 19950251
[TBL] [Abstract][Full Text] [Related]
38. Dual cooperative allosteric modulation of binding to ionotropic glycine receptors.
Maksay G; Bíró T
Neuropharmacology; 2002 Dec; 43(7):1087-98. PubMed ID: 12504915
[TBL] [Abstract][Full Text] [Related]
39. The glycine receptor.
Rajendra S; Lynch JW; Schofield PR
Pharmacol Ther; 1997; 73(2):121-46. PubMed ID: 9131721
[TBL] [Abstract][Full Text] [Related]
40. The human glycine receptor beta subunit: primary structure, functional characterisation and chromosomal localisation of the human and murine genes.
Handford CA; Lynch JW; Baker E; Webb GC; Ford JH; Sutherland GR; Schofield PR
Brain Res Mol Brain Res; 1996 Jan; 35(1-2):211-9. PubMed ID: 8717357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
